Chemi Pharmaceutical Inc. Enters into Collaboration Agreement with Revive Therapeutics for Research, Development and Analytical Testing of Medical Cannabis

MISSISSAUGA, ONTARIO–(Dec. 18, 2017) – Chemi Pharmaceutical Inc. (“Chemi Pharma” or the “Company”), a company focused on the analytical testing and research and development for the healthcare sector, is pleased to announce that the Company has entered into a collaboration agreement (the “Agreement”) with Revive Therapeutics Ltd. (“Revive”) (TSX VENTURE:RVV)(OTCQB:RVVTF), for the research, development and analytical testing of medical cannabis.  The Agreement with Revive positions Chemi Pharma’s commitment to the medical cannabis market and opens opportunities for Chemi Pharma to expand on its operations and build on its core competencies in research and analytical testing.

“We are very excited to collaborate with Revive on its initiatives of advancing novel medical cannabis products and technologies that leverages our core competencies and passion for healthcare solutions, including medical cannabis,” said Emil Stavrikov, Chief Executive Officer and Founder of Chemi Pharma. “We look forward to advancing our relationship with Revive and the potential of our next phase of growth in our businesses.”

“We are very excited with our collaboration with Chemi Pharma as it serves as an important part of our strategy in becoming a global leader in the medical cannabis industry while unlocking opportunities in partnering with pharmaceutical companies and licensed producers of medical cannabis,” said Fabio Chianelli, President of Revive. “We have an established relationship with Chemi Pharma and their commitment to quality research and testing under GMP and GLP paves the way for valuable opportunities in the medical cannabis market, which are only made available with a Dealer’s License. Revive is also exploring the potential of developing novel cannabis testing products and services that may be enabled by blockchain and artificial intelligence.”

About Revive Therapeutics Ltd.

Revive Therapeutics Ltd. (TSX VENTURE:RVV)(OTCQB:RVVTF) is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and pharmaceutical sectors. Additional information on Revive is available at

About Chemi Pharmaceutical Inc.

Founded in 2001, Chemi Pharma serves the Pharmaceutical, Natural Health Product, Cosmetics, Veterinary, and Cannabis industries with a wide range of quality control analytical testing and research and development services under Good Manufacturing Practice (“GMP”) and Good Laboratory Practice (“GLP”). Chemi Pharma is a Licensed Dealer pursuant to the Controlled Drugs and Substances Act under Health Canada and holds an Establishment License from Health Canada and Inspections from U.S. Food and Drug Administration. Additional information on Chemi Pharma is available at